Patients Are Dying Because Of Drug Shortages

A massive shortage of drugs is threatening the lives of patients across the United States. This year, 213 drugs are in short supply and doctors are forced to ration them. Drug rationing? Sounds like something a developing country might struggle with. But here in the United States it’s not even a new thing. Last year there were 211 scarce drugs, and patients have died as a result.

Stories of patients losing their battles with disease have been bubbling to the surface for weeks. US ABC told the story of Brigham Robust, who waited for weeks for a chemotherapy drug to treat his lymphoma. When he finally underwent treatment, it was too late. He lost his battle with cancer in September.

NPR reported today on a mother who administers an intravenous drip to her 15-year-old son daily because it’s the only way he can get nutrients. “A year ago, his small intestine suddenly kinked, cutting off its blood supply. Surgeons had to remove the entire small bowel.” Recently, his pharmacy ran out of calcium gluconate, which is vital for teeth and bones. But the nutrient has been rationed to patients who need it even more than him: premature infants in critical care.

Why is the US experiencing a drug shortage? It’s mostly a problem for injected drugs, which present unique manufacturing problems. Only about six companies make them. They can become contaminated relatively easily, which often prompts the companies to abandon production. Profit margins are slim. Injectables are harder to produce and take longer to make than pills. Also, there’s no regulation forcing drug makers to report manufacturing issues that might lead to shortages.

That’s why Minnesota Senator Amy Klobuchar introduced the Preserving Access to Life-Saving Medications Act, which would require drug makers to tell the FDA about potential shortages six months in advance. The FDA could penalise companies $US10,000 a day for unreported violations, with penalties capped at $US1.8 million. In February, the Senate referred the bill to the Committee on Health, Education, Labour and Pensions — which kind of has a lot on its plate at the moment.

[Associated Press, ABC, NPR]

Image: Shutterstock/Africa Studio

Discuss

(6 Comments)
  • [–]

    EckyThump

    Tuesday, October 4, 2011 at 9:34 AM

    “Profit Margins” is the catch phrase here! I wonder how many drugs simply don’t have enough patients to warrant even making it anymore, because they don’t make money on it! Not that it would really matter I suppose! because the average Joe who needed it no doubt couldn’t afford it anyway! “Profit Margins!!

    • [–]

      Steve

      Tuesday, October 4, 2011 at 8:08 PM

      You’ll be shocked at how narrow pharmaceutical company profit margins are. I know at my work, the drug reps show up every now and then to woo us to prescribe their product with free lunches etc. This is because they NEED patients to choose them over the generic to simply stay afloat.

      The cost of R&D, trials, legal red-tape from increased regulation is staggering.

      • [–]

        EckyThump

        Wednesday, October 5, 2011 at 9:04 AM

        Yeah, I have no doubt that the poor buggers on the sales end are being hurt too! It’s the manufacturers I’m talking about! #]

  • [–]

    Nathan

    Tuesday, October 4, 2011 at 11:26 AM

    Put everything about this in a bin and set it on fire. Then head to Wall Street.

  • [–]

    DarthDVD

    Tuesday, October 4, 2011 at 1:00 PM

    and the yanks are scared of healthcare being in the hands of the gov. look how good it is when only commercial interest’s are the only factors in consideration not the social.

  • [–]

    chugs

    Wednesday, October 5, 2011 at 11:54 AM

    sounds like some shrills and publicity firms are trying to talk up a problem.

Join The Discussion